Concepedia

Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses

Chun‐Jen Liu, Wan‐Long Chuang, Chuan–Mo Lee, Ming‐Lung Yu, Sheng‐Nan Lu, Shun‐Sheng Wu, Li‐Ying Liao, Chi‐Ling Chen, Hsing‐Tao Kuo, You‐Chen Chao,

Gastroenterology · 2008 · 212 citations · 35 references

DOIFull text

Open access

Concepts

References

35

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection

Michael Fried, Mitchell L. Shiffman, K. Rajender Reddy et al. · New England Journal of Medicine · 2002 · 6.4K citations

, , +17

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Michael P. Manns, John G. McHutchison, Stuart C. Gordon et al. · The Lancet · 2001 · 6.1K citations

, , +17

Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus

Thierry Poynard, Patrick Marcellin, Samuel S. Lee et al. · The Lancet · 1998 · 2.3K citations

, , +17

Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B

George Lau, Teerha Piratvisuth, Kang Luo et al. · New England Journal of Medicine · 2005 · 1.5K citations · Full text

, , +14

Peginterferon Alfa-2a in Patients with Chronic Hepatitis C

Stefan Zeuzem, S.V. Feinman, J. Rasenack et al. · New England Journal of Medicine · 2000 · 1.2K citations · Full text

, , +14